SGLT-2 inhibitors Clinical Trials

1 actively recruiting trial across 1 location

Filter by location:

Minneapolis, Minnesota1 trial

Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI

Minneapolis Heart Institute Foundation

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.